









Mercado
/
Acciones
/
nasdaq-iqv
/

IQVIA Holdings Inc

IQV

187.490USD

+6.530+3.61%

Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min

31.80BCap. mercado

23.70P/E TTM



IQVIA Holdings Inc

187.490

+6.530+3.61%

Descripción general Finanzas Análisis Compañía

Descripción general

Finanzas

Análisis

Compañía

Más Datos de IQVIA Holdings Inc Compañía

IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.

Información de IQVIA Holdings Inc



Símbolo de cotizaciónIQV

Nombre de la empresaIQVIA Holdings Inc

Fecha de salida a bolsaMay 09, 2013

Director ejecutivoBousbib (Ari)

Número de empleados88000

Tipo de seguridadOrdinary Share

Fin del año fiscalMay 09

Dirección2400 Ellis Road

CiudadDURHAM

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísUnited States of America

Código postal27703

Teléfono19199982000

Sitio Webhttps://ir.iqvia.com/

Símbolo de cotizaciónIQV

Fecha de salida a bolsaMay 09, 2013

Director ejecutivoBousbib (Ari)

Ejecutivos de IQVIA Holdings Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Ari Bousbib

Chairman of the Board, Chief Executive Officer

1.35M

Mr. Ronald E. (Ron) Bruehlman

Chief Financial Officer, Executive Vice President

46.46K

-907.00%

Mr. John G. Danhakl

Independent Director

30.85K

-117138.00%

Mr. Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

21.11K

Ms. Colleen A. Goggins

Independent Director

16.83K

+1592.00%

Dr. John M. Leonard, M.D.

Lead Independent Director

15.38K

+1592.00%

Ms. Carol J. Burt

Independent Director

7.01K

+1047.00%

Mr. James A. Fasano

Independent Director

2.74K

+1676.00%

Mr. John P. Connaughton

Independent Director

1.05K

+1047.00%

Mr. Bhavik Patel

President, Commercial Solutions

863.00

-84.00%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Ari Bousbib

Chairman of the Board, Chief Executive Officer

1.35M

Mr. Ronald E. (Ron) Bruehlman

Chief Financial Officer, Executive Vice President

46.46K

-907.00%

Mr. John G. Danhakl

Independent Director

30.85K

-117138.00%

Mr. Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

21.11K

Ms. Colleen A. Goggins

Independent Director

16.83K

+1592.00%

Dr. John M. Leonard, M.D.

Lead Independent Director

15.38K

+1592.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

La empresa aún no ha revelado los datos relevantes.

Por regiónUSD

Nombre

Ganancia

Proporción

Americas

1.93B

47.15%

Europe & Africa Region

1.30B

31.63%

Asia Pacific Region

870.00M

21.22%

Por negocio

Por región

La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: sáb., 10 de ene

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

11.54%

Harris Associates L.P.

6.71%

BlackRock Institutional Trust Company, N.A.

5.57%

State Street Investment Management (US)

4.45%

GIC Private Limited

3.86%

Otro

67.87%

Accionistas

Proporción

The Vanguard Group, Inc.

11.54%

Harris Associates L.P.

6.71%

BlackRock Institutional Trust Company, N.A.

5.57%

State Street Investment Management (US)

4.45%

GIC Private Limited

3.86%

Otro

67.87%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

47.72%

Investment Advisor/Hedge Fund

36.41%

Sovereign Wealth Fund

4.96%

Pension Fund

4.15%

Hedge Fund

3.24%

Research Firm

2.37%

Bank and Trust

2.01%

Individual Investor

0.92%

Family Office

0.15%

Participación institucional



Actualizado: jue., 1 de ene

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

2121

171.05M

100.44%

-15.70M

2025Q3

2061

175.98M

103.33%

-829.63K

2025Q2

2053

166.70M

98.05%

-9.45M

2025Q1

2083

168.53M

97.38%

-9.36M

2024Q4

2059

171.87M

97.45%

+3.00M

2024Q3

2008

173.01M

95.44%

+863.78K

2024Q2

1977

164.85M

90.43%

-7.68M

2024Q1

1950

165.50M

90.84%

-10.38M

2023Q4

1948

168.90M

93.03%

-6.38M

2023Q3

1925

170.01M

92.82%

-4.41M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

19.41M

11.4%

-186.59K

-0.95%

Sep 30, 2025

Harris Associates L.P.

11.39M

6.69%

-365.92K

-3.11%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

9.44M

5.54%

+67.42K

+0.72%

Sep 30, 2025

State Street Investment Management (US)

7.55M

4.43%

-75.92K

-1.00%

Sep 30, 2025

GIC Private Limited

6.54M

3.84%

-2.59M

-28.36%

Mar 31, 2025

Geode Capital Management, L.L.C.

4.35M

2.55%

+132.36K

+3.14%

Sep 30, 2025

CPP Investments

4.12M

2.42%

-52.91K

-1.27%

Sep 30, 2025

AllianceBernstein L.P.

3.60M

2.11%

+41.64K

+1.17%

Sep 30, 2025

Boston Partners

3.56M

2.09%

+1.58M

+80.09%

Sep 30, 2025

Artisan Partners Limited Partnership

3.43M

2.02%

+161.09K

+4.92%

Sep 30, 2025

ETFs relacionados



Actualizado: mar., 2 de dic

Nombre

Proporción

First Trust Nasdaq Lux Digi Health Solutions ETF

9.1%

Langar Global HealthTech ETF

7.83%

Global X HealthTech ETF

5.5%

VanEck Biotech ETF

4.98%

iShares Biotechnology ETF

3.23%

iShares Health Innovation Active ETF

3.05%

Adaptive Core ETF

3.04%

Invesco Bloomberg Pricing Power ETF

2.24%

Running Oak Efficient Growth ETF

2.16%

Invesco Zacks Mid-Cap ETF

2.08%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporción9.1%

Langar Global HealthTech ETF

Proporción7.83%

Global X HealthTech ETF

Proporción5.5%

VanEck Biotech ETF

Proporción4.98%

iShares Biotechnology ETF

Proporción3.23%

iShares Health Innovation Active ETF

Proporción3.05%

Adaptive Core ETF

Proporción3.04%

Invesco Bloomberg Pricing Power ETF

Proporción2.24%

Running Oak Efficient Growth ETF

Proporción2.16%

Invesco Zacks Mid-Cap ETF

Proporción2.08%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

KeyAI

